CLINICAL_TRIALS
trial_result
· 2011-05-17
Clinical Trial Update: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]
Summary
Phase 4 trial assessing the effects of risperidone and olanzapine on blood glucose in patients with schizophrenia or schizoaffective disorder; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen, LP | Conditions: Schizophrenia, Diabetes Mellitus | Phase 4 | Status: COMPLETED